KID-T, a unique polyherbal extract, improves feline patients with azotemia and uremia: A pilot study https://doi.org/10.12982/VIS.2023.045
Article Sidebar
Main Article Content
Abstract
Cats with azotemia and uremia are increasingly treated with integrative and alternative treatments, including herbal medicines. KID-T (Sin-gi-hwan) is a supplement made of 100% natural herbs and contains 18 herbs, and the components were designed to improve renal function in. Feline renal patients with azotemia and uremia were recruited, and the efficacy of KID-T was examined. Four cats were treated with oral KID-T twice a day for 3 months, and blood biochemical profiles were examined to monitor the toxicity and efficacy of KID-T each month. KID-T was well-tolerated and relatively safe during the treatment period. After 3 months, ammonia, blood urea nitrogen, and creatinine levels were relatively close to the normal reference range in all cats, and the urine protein–creatinine ratio decreased. Biochemical profile and clinical examination exhibited a stabilized status of renal function for 3 months. Overall, KID-T improves and maintains feline renal function, and future studies should evaluate other potential benefits of KID-T in feline renal patients, including correlative assessments of renal function, quality of life improvement, and patient-owner satisfaction.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publishing an article with open access in Veterinary Integrative Sciences leaves the copyright with the author. The article is published under the Creative Commons Attribution License 4.0 (CC-BY 4.0), which allows users to read, copy, distribute and make derivative works from the material, as long as the author of the original work is cited.
References
AAdagra, C., Foster, D.J., 2015. Hyperammonaemia in four cats with renal azotaemia. J.Feline. Med. Surg. 17(2), 168-172.
Bartges, J.W., 2012. Chronic kidney disease in dogs and cats. Vet. Clin. North. Am. Small.Anim. Pract. 42(4), 669-692.
Carvalho, L., Kelley, D., Labato, M.A., Webster, C.R., 2021. Hyperammonemia in azotemic cats. J. Feline. Med. Surg. 23(8), 700-707.
Donato, L.J., 2010. Acupuncture, Chinese herbal medicine, Tui-na and food therapy integrated with other treatments for chronic renal disease of a cat. Am. J. Tradit. Chinese Med.5(2), 61-69.
Elliott, D.A., 2006. Nutritional management of chronic renal disease in dogs and cats. Vet.Clin. North. Am. Small. Anim. Pract. 36(6), 1377-1384.
Huang, K.C., Su, Y.C., Sun, M.F., Huang, S.T., 2018. Chinese herbal medicine improves the long-term survival rate of patients with chronic kidney disease in Taiwan: a nationwide retrospective population-based cohort study. Front. Pharmacol. 9, 1117.
Imran, M., Shah, Y., Nundlall, S., Roberts, N.B., Howse, M., 2012. Is blood ammonia influenced by kidney function? A prospective study. Clin. Biochem. 45(4-5),363-365.
Korman, R.M., White, J.D., 2013. Feline CKD: Current therapies–what is achievable?. J.Feline. Med. Surg. 15(1suppl), 29-44.
Lulich, J., 1992. Feline renal failure: questions, answers, questions. Comp. Cont. Educ. Pract.Vet. 14, 127-152.
Matchimakul, P., 2018. Diagnostic biomarker SDMA for kidney disease in dogs and cats. Vet.Integr. Sci. 16(3), 145-158.
Narasimhan, L.R., Goodman, W., Patel, C.K., 2001. Correlation of breath ammonia with blood urea nitrogen and creatinine during hemodialysis. Proc. Natl. Acad. Sci. U.S.A. 98(8),4617-4621.
Polzin, D.J., 2011. Chronic kidney disease in small animals. Vet. Clin. North. Am. Small.Anim. Pract. 41(1), 15-30.
Polzin, D.J., 2013. Evidence-based step-wise approach to managing chronic kidney disease in dogs and cats. J Vet Emerg Crit Care (San Antonio). 23(2), 205-215.
Qiu, H., Fu, P., Fan, W., Zuo, C., Feng, P., Shi, P., Cao, L., Liu, F., Zhou, L., Chen, F., Zhong, H., Gou, Z., Liang, Y., Shi, M., 2014. Treatment of primary chronic glomerulonephritis with rehmannia glutinosa acteosides in combination with the angiotensin receptor blocker irbesartan: A randomized controlled trial. Phytother. Res. 28(1), 132-136.
Roudebush, P., Polzin, D.J., Ross, S.J., Towell, T.L., Adams, L.G., Dru Forrester, S., 2009.Therapies for feline chronic kidney disease. What is the evidence?. J. Feline. Med.Surg. 11(3), 195-210.
Sparkes, A.H., Caney, S., Chalhoub, S., Elliott, J., Finch, N., Gajanayake, I., Langston, C.,Lefebvre, H.P., White, J., Quimby, J., 2016. Isfm consensus guidelines on the diagnosis and management of feline chronic kidney disease. J Feline Med Surg. 18(3), 219-239.
White, J.D., Stevenson, M., Malik, R., Snow, D., Norris, J.M., 2013. Urinary tract infections in cats with chronic kidney disease. J. Feline. Med. Surg. 15(6), 459-465.
Wynn, S.G., Marsden, S., 2003. Therapies for urologic disorders. In: Wynn, S.G., Marsden, S.(Eds.), Manual of natural veterinary medicine: science and tradition. Mosby, United States, pp. 565-607.
Wynn, S.G., Fougère, B.J., 2007. Veterinary herbal medicine: a systems-based approach, In:Wynn, S.G., Fougère, B.J. (Eds.), Veterinary herbal medicine. Mosby, Saint Louis, pp.291-409.
Yuan, A., Liu, C., Huang, X., 1998. Treatment of 34 cases of chronic aplastic anemia using prepared Rehmannia polysaccharide associated with stanozolol. Zhongguo. Zhong. Xi. Yi. Jie. He. Za. Zhi. 18(6), 351-353.